1. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;
2. Division of Cancer and Haematology, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia;
3. Clinical Hematology, Peter MacCallum Cancer Center, Royal Melbourne Hospital, Parkville, VIC, Australia;
4. Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia;
5. Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia;
6. National Genetic Center, Royal Hospital, Ministry of Health, Muscat, Sultanate of Oman;
7. Division of Molecular Medicine, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia;
8. Division of Translational Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany;
9. German Cancer Consortium, Heidelberg, Germany; and
10. Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg, Germany